2Liu Y, Geng W, Yang Y, et al. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus attreus isolated from Chinese children with skin and soft tissue infections [J]. FEMS Im- munol Med Microbiol, 2012, 64 (2) : 212-218.
3Park MR, Kim DS, Kim J, et al. Anaphylaxis to topically ap- plied sodium fusidate [J]. Allergy Asthma Immunol Res, 2013, 5 (2) : 110-112.
4Kraus CN, Burnstead BW. The safety record of fusidic acid in non-US markets: a focus on skin infections [J]. Clin Infect Dis, 2011, 52 (7) : S527-S537.
5Schefer H, Simonsen L. Fusidic acid in dermatology: an updated review [J].EurJDermatol, 2010, 20 (1) : 6-15.
6Koning S, Van Suijlekom-Smit LW, Nouwen JL, et al. Fusidic acid cream in the treatment of impetigo in general practice : double blind randomised placebo controlled trial [J]. BMJ, 2002, 324 (7331) : 203-206.
7Koning S, Van SR, Verhagen AP, et al. Interventions for impeti- go [J]. Cochrane Database Syst Rev, 2012, ( 1 ) : CD003261.
2Ishida N, Nakaminami H, Noguchi N, et al. Antimicrobial sus- ceptibilities of Propionibacterium ances isolated from patients with vulgaris. Microbiol Immunol, 2008,52 (12) : 621- 624.
3Sommer S, Bojar R, Cunliffe WJ, et al. Investigation of the mechanism of action of 2% fusidic acid lotion in the treatment of acne vulgaris. Clin Exp Dermatol, 1997,22 (5) : 211- 225.
